Radiology solutions provider Qure.ai will be working with the Italian San Raffaele University Hospital to monitor disease progression in COVID-19 patients.
Martina Badini / shutterstock.com
Qure.ai’s automated chest X-ray solution, qXR, interprets a COVID-19 patient’s lung scans in seconds and quantifies how much of their lungs have been affected by the viral infection.
COVID-19 patients need frequent monitoring of their lung infection using chest X-rays but quantifying the extent of the infection is a time-consuming step for already overloaded radiologists. Qure.ai’s qXR can detect findings like ground-glass opacities and consolidation abnormalities that are indicative of COVID-19. The AI-powered solution also helps detect tuberculosis, chronic obstructive pulmonary diseases, lung malignancies and medical emergencies like lung collapses and cardiac disorders. It can also localise lesions and quantify the volume of an infection.
Prashant Warier, CEO and co-founder of Qure.ai, said: "By using our technology, doctors can objectively monitor disease progression in a COVID-19 patient and their response to new therapeutic approaches.
“Our expertise with tackling Tuberculosis has served us well in developing AI solutions to fight the COVID-19 pandemic. The algorithm we’ve created will help to reduce the workload of hospital staff, as well as to devise the best treatment options for patients, at different stages of COVID-19. We believe the technology will also help to aid in the discovery of new drugs and therapeutic approaches.”
